Analysis of mtDNA, miR-155 and BACH1 expression in hearts from donors with and without Down syndrome

References

• Arbuzova S, Hutchin T, Cuckle H. (2002). Mitochondrial dysfunction and Down's syndrome. Bioessays 24:681–4
   PubMed Web of Science ®Google Scholar
• Broder H, Gottlieb RA, Lepor N E. (2008). Chemotherapy and cardiotoxicity. Rev Cardiovasc Med 9:75–83
   PubMed Web of Science ®Google Scholar
• Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, et al. (2009). The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–22
   PubMed Web of Science ®Google Scholar
• Conti A, Fabbrini F, D'agostino P, Negri R, Greco D, Genesio R, D'armiento M, et al. (2007). Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy. BMC Genomics 8:268
   PubMed Web of Science ®Google Scholar
• Coskun PE, Busciglio J. (2012). Oxidative Stress and mitochondrial dysfunction in Down's syndrome: Relevance to aging and dementia. Curr Gerontol Geriatr Res 7
   Google Scholar
• Coskun PE, Wyrembak J, Derbereva O, Melkonian G, Doran E, Lott IT, Head E, et al. (2010). Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia. J Alzheimers Dis 20:S293–310
   PubMed Web of Science ®Google Scholar
• Faraoni I, Antonetti FR, Cardone J, Bonmassar E. (2009). miR-155 gene: A typical multifunctional microRNA. Biochimica Et Biophysica Acta 1792:497–505
   PubMed Web of Science ®Google Scholar
• Grenier MA, Lipshultz SE. (1998). Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol 25:72–85
   PubMed Web of Science ®Google Scholar
• Hsu CW, Yin PH, Lee HC, Chi CW, Tseng L M. (2010). Mitochondrial DNA content as a potential marker to predict response to anthracycline in breast cancer patients. Breast J 16:264–70
   PubMed Web of Science ®Google Scholar
• Ide T, Tsutsui H, Hayashidani S, Kang D, Suematsu N, Nakamura K, Utsumi H, et al. (2001). Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 88:529–35
   PubMed Web of Science ®Google Scholar
• Infantino V, Castegna A, Iacobazzi F, Spera I, Scala I, Andria G, Iacobazzi V. (2011). Impairment of methyl cycle affects mitochondrial methyl availability and glutathione level in Down's syndrome. Mol Genet Metab 102:378–82
   PubMed Web of Science ®Google Scholar
• Kalabus JL, Sanborn CC, Jamil RG, Cheng Q, Blanco JG. (2010). Expression of the anthracycline-metabolizing enzyme carbonyl reductase 1 in hearts from donors with Down syndrome. Drug Metab Dispos 38:2096–9
   PubMed Web of Science ®Google Scholar
• Kluza J, Marchetti P, Gallego MA, Lancel S, Fournier C, Loyens A, Beauvillain JC, Bailly C. (2004). Mitochondrial proliferation during apoptosis induced by anticancer agents: Effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Oncogene 23:7018–30
   PubMed Web of Science ®Google Scholar
• Krischer JP, Epstein S, Cuthbertson DD, Goorin AM, Epstein ML, Lipshultz SE. (1997). Clinical cardiotoxicity following anthracycline treatment for childhood cancer: The pediatric oncology group experience. J Clin Oncol 15:1544–52
   PubMed Web of Science ®Google Scholar
• Krishnan KJ, Reeve AK, Samuels DC, Chinnery PF, Blackwood JK, Taylor RW, Wanrooij S, et al. (2008). What causes mitochondrial DNA deletions in human cells? Nat Genet 40:275–9
   PubMed Web of Science ®Google Scholar
• Larsson NG, Wang J, Wilhelmsson H, Oldfors A, Rustin P, Lewandoski M, Barsh GS, Clayton DA. (1998). Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet 18:231–6
   PubMed Web of Science ®Google Scholar
• Lezza AM, Boffoli D, Scacco S, Cantatore P, Gadaleta MN. (1994). Correlation between mitochondrial DNA 4977-bp deletion and respiratory chain enzyme activities in aging human skeletal muscles. Biochem Biophys Res Commun 205:772–9
   PubMed Web of Science ®Google Scholar
• Marin-Garcia J, Goldenthal MJ, Ananthakrishnan R, Pierpont ME, Fricker FJ, Lipshultz SE, Perez-Atayde A. (1996). Specific mitochondrial DNA deletions in idiopathic dilated cardiomyopathy. Cardiovasc Res 31:306–13
   PubMed Web of Science ®Google Scholar
• Mccabe LL, Mccabe ER. (2011). Down syndrome: Issues to consider in a national registry, research database and biobank. Mol Genet Metab 104:10–12
   PubMed Web of Science ®Google Scholar
• Meissner C, Bruse P, Mohamed SA, Schulz A, Warnk H, Storm T, Oehmichen M. (2008). The 4977 bp deletion of mitochondrial DNA in human skeletal muscle, heart and different areas of the brain: a useful biomarker or more? Exp Gerontol 43:645–52
   PubMed Web of Science ®Google Scholar
• Menna P, Recalcati S, Cairo G, Minotti G. (2007). An introduction to the metabolic determinants of anthracycline cardiotoxicity. Cardiovasc Toxicol 7:80–5
   PubMed Web of Science ®Google Scholar
• Menna P, Salvatorelli E, Minotti G. (2008). Cardiotoxicity of Antitumor Drugs. Chem Res Toxicol 21:978–89
   PubMed Web of Science ®Google Scholar
• Miller FJ, Rosenfeldt FL, Zhang C, Linnane AW, Nagley P. (2003). Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: Lack of change of copy number with age. Nucleic Acids Res 31:e61
   PubMed Web of Science ®Google Scholar
• Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. (2004). Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185–229
   PubMed Web of Science ®Google Scholar
• Mohamed SA, Hanke T, Erasmi AW, Bechtel MJ, Scharfschwerdt M, Meissner C, Sievers HH, Gosslau, A. (2006). Mitochondrial DNA deletions and the aging heart. Exp Gerontol 41:508–17
   PubMed Web of Science ®Google Scholar
• O'brien MM, Taub JW, Chang MN, Massey GV, Stine KC, Raimondi SC, Becton D, et al. (2008). Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: A report from the Children's Oncology Group Study POG. (9421). J Clin Oncol 26:414–20
   PubMed Web of Science ®Google Scholar
• Ogawa O, Perry G, Smith MA. (2002). The “Down's” side of mitochondria. Dev Cell 2:255–6
   PubMed Web of Science ®Google Scholar
• Oster-Granite ML, Parisi MA, Abbeduto L, Berlin DS, Bodine C, Bynum D, Capone G, et al. (2011). Down syndrome: National conference on patient registries, research databases, and biobanks. Mol Genet Metab 104:13–22
   PubMed Web of Science ®Google Scholar
• Pallardo FV, Lloret A, Lebel M, D'ischia M, Cogger VC, Le Couteur DG, Gadaleta MN, et al. (2010). Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome. Biogerontology 11:401–19
   PubMed Web of Science ®Google Scholar
• Pereira GC, Silva AM, Diogo CV, Carvalho FS, Monteiro P, Oliveira PJ. (2011). Drug-induced cardiac mitochondrial toxicity and protection: From doxorubicin to carvedilol. Curr Pharm Des 17:2113–29
   PubMed Web of Science ®Google Scholar
• Prandini P, Deutsch S, Lyle R, Gagnebin M, Delucinge Vivier C, Delorenzi M, Gehrig C, et al. (2007). Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. Am J Hum Genet 81:252–63
   PubMed Web of Science ®Google Scholar
• Pulkkinen KH, Ylä-Herttuala S, Levonen A-L. (2011). Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells. Free Radic Biol Med 51:2124–31
   PubMed Web of Science ®Google Scholar
• Ravindranath Y, Chang M, Steuber CP, Becton D, Dahl G, Civin C, Camitta B, et al. (2005). Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): A review of four consecutive childhood AML trials conducted between 1981 and. (2000). Leukemia 19:2101–16
   PubMed Web of Science ®Google Scholar
• Roat E, Prada N, Ferraresi R, Giovenzana C, Nasi M, Troiano L, Pinti M, et al. (2007). Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome. FEBS Lett 581:521–5
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101–8
   PubMed Web of Science ®Google Scholar
• Shanske S, Tang Y, Hirano M, Nishigaki Y, Tanji K, Bonilla E, Sue C, et al. (2002). Identical mitochondrial DNA deletion in a woman with ocular myopathy and in her son with pearson syndrome. Am J Hum Genet 71:679–83
   PubMed Web of Science ®Google Scholar
• Shenkar R, Navidi W, Tavare S, Dang MH, Chomyn A, Attardi G, Cortopassi G, Arnheim N. (1996). The mutation rate of the human mtDNA deletion mtDNA4977. Am J Hum Genet 59:772–80
   PubMed Web of Science ®Google Scholar
• Sterba M, Popelova O, Lenco J, Fucikova A, Brcakova E, Mazurova Y, Jirkovsky E, et al. (2011). Proteomic insights into chronic anthracycline cardiotoxicity. J Mol Cell Cardiol 50:849–62
   PubMed Web of Science ®Google Scholar
• Sykiotis GP, Bohmann D. (2010). Stress-activated cap‘n’collar transcription factors in aging and human disease. Sci Signal 3:re3
   PubMed Web of Science ®Google Scholar
• Tang S, Huang T. (2010). Characterization of mitochondrial DNA heteroplasmy using a parallel sequencing system. Biotechniques 48:287–96
   PubMed Web of Science ®Google Scholar
• Taub JW, Ravindranath Y. (2011). What's up with down syndrome and leukemia-A lot! Pediatr Blood Cancer 57:1–3
   PubMed Web of Science ®Google Scholar
• Wallace DC. (1992). Diseases of the mitochondrial DNA. Annu Rev Biochem 61:1175–212
   PubMed Web of Science ®Google Scholar